On this page
The research desk’s view
Live Vital supplies a specific MOTS-c service entry with a stated payment interval. The metabolic research question remains separate: the listing does not establish that native-peptide treatment reproduces an analogue trial or changes a meaningful patient outcome.
The listing, in detail
- Published offering
- MOTS-c subcutaneous injectable, subject to clinician review.
- Starting price
- $399 every two months; marketed as starting at $200/month.
- Billing & renewal
- Read the selected product’s purchase period and renewal terms in the review.
- Verification scope
- Exact pharmacy assignment, individual licensure and dispensed-product quality not independently verified.
What the listing establishes
- Dedicated product entry names the proposed preparation.
- A specific purchase period and total are published.
What it leaves unanswered
- A public listing does not establish a clinical outcome or personal eligibility.
- The retrieved no-prescription payment policy needs a written answer.
Partner link. We may earn a commission.
The charged amount is the comparison unit
The recurring total is more useful than a rounded monthly equivalent. Compare the full two-month payment with the same dates from another provider. Ask what quantity and included care that payment buys, and which charges would change if the clinician changes the proposed treatment. The cost planner can make the timelines visible.
Native peptide and analogue evidence differ
A paper about the body’s naturally occurring MOTS-c, an experiment administering a peptide and a clinical report about an analogue address different interventions. The product label does not bridge those gaps. Read the exact preparation and study population before accepting a general energy or metabolism description as evidence of benefit.
Follow-up is a question worth making concrete
The provider describes clinician review and continuing contact, but a reader still needs the actual care arrangement. Ask who reviews concerns, what would trigger further assessment and which clinician or pharmacy is responsible for the prescription. The consultation questions guide helps turn a broad support description into specific requests.
Keep the unresolved purchase term visible
The no-prescription payment/refund answer is incomplete in the retrieved policy. Obtain it before committing. The Rx Peps Direct review offers a different order-based service model for comparison. Its lower purchase unit should not be treated as a lower full cost until the proposed quantities, repeat fees and care periods are aligned.
Read the source
Research findings and provider statements are different evidence.
- Live Vital: dedicated product recordCompany website
- Live Vital: published refund policyCompany website
- Live Vital: state availabilityCompany website